• Clinical Insights: August 11, 2017

    Welcome to the weekly edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place.   New Drug Approval CaroSpir® (spironolactone) – August 7, 2017 – CMP Pharma announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the company’s New… Read more »

  • June 340B Insider

    Welcome to the June edition of RxStrategies 340B Insider, a concise communication to provide a quick highlight of updates from RxStrategies’ view.   340B UPDATES   21st Century Cures Act Moves Forward Without 340B Language On May 21, the House Energy and Commerce Committee unanimously approved the 21st Century Cures Act (H.R. 6) without the inclusion of… Read more »

  • March 340B Insider

      Welcome to the March edition of RxStrategies 340B Insider, a concise communication to provide a quick highlight of updates from RxStrategies’ view.   UPDATE FROM 340B COALITION WINTER CONFERENCE   RxStrategies’ Increased Presence at 340B Coalition Winter Conference RxStrategies continues to work closely with SNHPA, as one of two Pinnacle Leader Corporate Partners, supporting educational… Read more »

  • December 340B Insider

    340B Winter Coalition Conference Mark your calendars for the 11th Annual 340B Coalition Winter Conference, from Feb. 4 to 6, 2015 at the Hyatt Regency Embarcadero in San Francisco. RxStrategies invites you to schedule a meeting time or stop by our booth #18-19 in the exhibit hall. Our team will greet you and answer any… Read more »